Targeted Oncology10d
Experts Discuss Tislelizumab’s FDA Approval in Esophageal Cancer
Ken Kato, MD, PhD, and Harry H. Yoon, MD, MHS, discussed the recent FDA approval of tislelizumab in the first line for ...
Business Wire19d
TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy
“FDA approval of TEVIMBRA for the first-line treatment of advanced esophageal squamous cell carcinoma marks a significant step forward in tackling the unmet needs in this challenging disease are ...
Targeted Oncology3d
Tislelizumab Gains FDA Nod in Advanced Esophageal Cancer
Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...
Medscape1mon
Basal Cell Carcinoma and the Carcinogenic Role of Aberrant Hedgehog Signaling
Several components of the hedgehog (Hh) pathway are crucial to basal cell carcinoma (BCC) tumorigenesis. Primary cilia have emerged as key organelles in Hh signal transduction in mammalian systems ...
Fred Hutch4y
Slobodan Beronja, PhD
Slobodan Beronja studies how our skin develops to better understand skin cancer, including squamous cell carcinoma. Because we constantly ... are essential for tissue growth during development and ...
Baylor College of Medicine4y
Head and Neck Squamous Cell Carcinoma
Surgical, radiation and medical oncologists in the Baylor St. Luke's Medical Center Dan L Duncan Comprehensive Cancer Center specialize in the diagnosis and treatment of head and neck squamous cell ...